Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.78 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.78 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.78 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.78 |
| ▸ | AR | P10275 | 1/20 | 0.78 |
| ▸ | TSHR | P16473 | 1/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | USP2 | O75604 | 1/20 | 0.78 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.78 |
| ▸ | ESR1 | P03372 | 1/20 | 0.78 |
| ▸ | TST | Q16762 | 1/20 | 0.78 |
| ▸ | MAPT | P10636 | 3/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | SREBF1 | P36956 | 1/20 | 0.68 |
| ▸ | VDR | P11473 | 4/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 25-Hydroxyergocalciferol- SCHEMBL15981129 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL19469428 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL15981131 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL10034123 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL9933379 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL465799 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL12464610 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL17274134 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL1879846 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL9933381 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2083 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260140108-A1 | EXTRACTION ROD AND PREPARATION METHOD THEREOF, AND METHOD FOR DETECTING 25-HYDROXYVITAMIN D | INNOVATION CENTER OF YANGTZE RIVER DELTA ZJU (CN) | 2026-05-21 | — | — | US | claimed |
| US-12607640-B2 | Mass spectrometry of steroidal compounds in multiplex samples | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2026-04-21 | — | — | US | claimed |
| EP-4711765-A2 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEX SAMPLES | Quest Diagnostics Investments Incorporated (US) | 2026-03-18 | — | — | EP | claimed |
| US-12576102-B2 | Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-17 | — | — | US | claimed |
| US-20260034148-A1 | STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME | EIRGEN PHARMA LTD. (IE) | 2026-02-05 | — | — | US | claimed |
| US-12478631-B2 | Stabilized modified release vitamin D formulation and method of administering same | EIRGEN PHARMA LTD. (IE) | 2025-11-25 | — | — | US | claimed |
| EP-3609491-B1 | OMEGA-3 FATTY ACID, HOMOCYSTEIN AND VITAMIN D LEVELS TO IDENTIFY AND ATTENUATE COGNITIVE AGING IN INDIVIDUALS | NESTLE SA (CH) | 2025-11-05 | — | — | EP | claimed |
| EP-3332788-B1 | TREATING VITAMIN D INSUFFICIENCY AND DEFICIENCY WITH 25-HYDROXYVITAMIN D2 AND 25-HYDROXYVITAMIN D3 | OPKO RENAL LLC (US) | 2025-10-15 | — | — | EP | claimed |
| EP-3335712-B1 | METHOD OF SAFELY AND EFFECTIVELY TREATING AND PREVENTING SECONDARY HYPERPARATHYROIDISM IN CHRONIC KIDNEY DISEASE | OPKO RENAL LLC (US) | 2025-09-10 | — | — | EP | claimed |
| EP-3225243-B1 | METHOD OF SAFELY AND EFFECTIVELY TREATING AND PREVENTING SECONDARY HYPERPARATHYROIDISM IN CHRONIC KIDNEY DISEASE | OPKO RENAL LLC (US) | 2025-09-03 | — | — | EP | claimed |
| EP-0594581-A1 | PRODUCTION OF GLYCOSIDES, ESPECIALLY OF STEROIDAL GLYCOSIDES | Klemke, Rudolf Erich, Dipl.-Chem. (DE) | 1994-05-04 | — | — | EP | claimed |
| EP-0587751-A1 | THERAPEUTIC COMPOSITIONS FOR OSTEOINDUCTION | THE PROCTER & GAMBLE COMPANY (US) | 1994-03-23 | — | — | EP | claimed |
| WO-1993001821-A1 | NOVEL GLYCOSIDE COMPOUNDS AND PRODUCTION AND USE THEREOF | HARRIER, INC. (US) | 1993-02-04 | — | — | WO | claimed |
| WO-1992021365-A1 | THERAPEUTIC COMPOSITIONS FOR OSTEOINDUCTION | THE PROCTER & GAMBLE COMPANY (US) | 1992-12-10 | — | — | WO | claimed |
| EP-0461921-A2 | Method for the biological preparation of hydroxyvitamin D compounds | MERCIAN CORPORATION (JP) | 1991-12-18 | — | — | EP | claimed |
| WO-1991011452-A1 | PRODUCTION OF GLYCOSIDES, ESPECIALLY OF STEROIDAL GLYCOSIDES | 'HARRIER' GMBH GESELLSCHAFT FÜR DEN VERTRIEB MEDIZINISCHER UND TECHNISCHER GERÄTE (DE) | 1991-08-08 | — | — | WO | claimed |
| WO-1990006121-A2 | METHOD FOR IMPROVING REPRODUCTIVE FUNCTIONS IN MAMMALS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1990-06-14 | — | — | WO | claimed |
| WO-1984004527-A1 | PROCESS FOR THE PREPARATION OF 1alpha,25-DIHYDROXYLATED VITAMIN D2 AND RELATED COMPOUNDS | WISCONSIN ALUMNI RES FOUND (US) | 1984-11-22 | — | — | WO | claimed |
| EP-0077353-A1 | 1-HYDROXYLATION PROCESS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1983-04-27 | — | — | EP | claimed |
| WO-1982003864-A1 | 1-HYDROXYLATION PROCESS | WISCONSIN ALUMNI RES FOUND (US) | 1982-11-11 | — | — | WO | claimed |